PLMO-02 - Plenary session – Antimicrobial resistance (AMR): Challenges, opportunities and sustainable solutions

Great Hall 3-4


Mrs Manjiri Sandeep Gharat, Vice President FIP and Chair of the FIP AMR Commission, India and Ms Fiona Doukas, FIP AMR Commission, Australia


Antimicrobial resistance (AMR) presents a global urgency. In 2018, FIP issued a statement of policy on AMR targeting pharmacists and their roles. In 2023, FIP renewed its commitment to minimise AMR with an updated statement of policy to be signed by its 156+ member organisations. 

There is recognition that policy action and worldwide collaboration is essential. Data plays a pivotal role in the battle against AMR by providing essential insights, informing decision-making, and driving evidence-based strategies.  

In this plenary session, we will explore various innovations and potential solutions to address AMR through global leadership. Speakers will reiterate the importance of favourable policy and a collaborative environment and will aspire to identify critical gaps and foster meaningful data intelligence strategies to effectively combat AMR. We invite the audience to actively participate in a panel discussion, contributing their perspectives on existing policies, commitments, and meaningful strategies to combat AMR effectively in 2024 and beyond.  


16:30 – 16:35  Introduction by the chairs
16:35 – 16:50

Enabling pharmacists to strengthen the health system during COVID-19 and beyond: Insights from the Queensland Government
Hon. Shannon Fentiman MP, Minister for Health, Mental Health and Ambulance Services, and Minister for Women for Queensland, Australia

16:50 – 16:55

High-level remarks – Global AMR priorities and the road to the UN General Assembly high-level meeting on AMR
Dr Jean-Pierre Nyemazi, Technical Officer, Unit head ai, Antimicrobial Resistance Division, WHO, Switzerland

16:55 – 17:00 WHO’s AWaRe system and AWaRe antibiotic book: a short introduction
Dr Benedikt Huttner​, Team Lead, Essential Medicines, Health Products Policy and Standards Department, WHO, Switzerland​
17:00 – 17:05 WHO technical work in the area The impact of substandard and falsified medicines in AMR and the need for a systems approach to sustainable solutions
Dr Pernette Bourdillon Esteve, Technical officer. Incidents and Substandard / Falsified Medical Products (ISF) Regulation and Safety WHO, Switzerland
17:05 – 17:15 Addressing the AMR Crisis with Data Intelligence: outlooks for a progress on the global challenges
Mr Murray Aitken, IQVIA Institute for Human Data Science, United States
17:15 – 17:25 FIP’s policies to minimise AMR: 2022 AMR Commitments and 2023 FIP Statement of Policy on AMR
Dr Luna El Bizri, FIP AMR Policy Committee/AMR Commission, Lebanon
17:25 – 17: 30 Q&A with the speakers and audience to consider AMR issues against the global commitments and identify the gaps for 2024
17:30 Closing by the chairs

Learning objectives

  1. Grasp the importance of addressing AMR as a global health priority, recognising its potential impact on healthcare systems, economies, and public well-being.
  2. Evaluate global approaches to mitigate antimicrobial resistance, understanding their potential effectiveness and implications for implementation.
  3. Assess existing policies, environments and commitments aimed at tackling AMR, explore use of data to support these commitments, and identify gaps for action for 2024.

Take home messages

AMR is a critical global concern requiring immediate attention. Policy commitments are essential for effective solutions, fostering innovative solutions which aim to combat AMR’s challenges. Data-driven approaches are vital to comprehensively tackle AMR.

By harnessing the power of data intelligence, we can make informed decisions, implement targeted interventions, and forge a united global response to safeguard the efficacy of antimicrobial agents and protect public health. Engaging discussions can identify gaps and foster progress for 2024; together, we can safeguard public health and ensure a healthier future.